Type 1 diabetes is an autoimmune disease in which the pancreas stops producing insulin, making it difficult to control blood sugar levels. It's rarer than type 2 diabetes and accounts for about 5 percent of all diabetes cases. It used to be called "juvenile-onset diabetes" because it often occurs in children and young adults, though it can occur in adulthood, as well.
Unlike type 2 diabetes, nothing can be done to prevent type 1 diabetes, which is thought to be caused by some combination of genetic factors and environmental triggers. It occurs when the immune system attacks the pancreas and destroys insulin-producing cells.
The hormone insulin is pivotal in allowing sugar to leave the blood stream and enter the cells. Without it, the sugar simply builds up in the blood, and cells in the body are gradually starved of the food they need to operate.
Warning signs for type 1 diabetes include drowsiness, weight loss, vision changes, extreme thirst, frequent urination, heavy breathing and loss of consciousness. They can come on quite suddenly and can lead to problems all over the body, including the nerves, kidneys, eyes and heart. Undiagnosed or untreated type 1 diabetes can lead to coma and even death.
The treatment for type 1 diabetes consists of regular doses of insulin. The amount and regularity of these doses will vary somewhat from person to person. The most common method of delivering insulin is via injection, with a syringe, but other methods also can be used, including pumps that are connected to the body and diffusers. Occasionally, people with type 1 diabetes may require other medications to manage their blood sugar or to help with complications that can arise from having type 1 diabetes.
SOURCES: U.S. Centers for Disease Control and Prevention; Juvenile Diabetes Research Foundation; Diabetes Research Institute Foundation; U.S. National Institute of Diabetes and Digestive and Kidney Diseases
Children who develop type 1 diabetes may be at increased risk of celiac disease, study finds
Study found young patients had better blood sugar control with insulin pump, but cost is higher
Screening for early signs of both conditions should be done at birth, study suggests
Start by setting the same rules for everyone in the family, specialist says
Insulinomas provide genetic maps for making insulin, researchers say
Odds of both type 2 and latent autoimmune diabetes rose when adults consumed more salt, study shows
The answer may depend on whether you're a man or a woman
Study suggests Norwegians hit by H1N1 flu pandemic more likely to develop the autoimmune disease
Next step is to see if it works and for how long
Patients saw lasting improvement while playing team-based diabetes education game, study found
2 out of 3 use a device that continuously tracks blood sugar on 'unapproved' body part, study finds
Neurologist says one causes burning pain, the other causes problems with heart rate and blood pressure
'Stem cell educator' provided at least 4 years' benefit for some people with type 1 or type 2 diabetes, study says
Surprising finding hints at potential future therapy
Previously purchased products may not have been stored properly, could lead to inaccurate results
Study suggests difference stems from both biological and care issues
New product much easier to use than rescue injections, researcher says
SLGT2 inhibitors can hike risk for condition known as diabetic ketoacidosis, research shows
More than 100,000 people are on the U.S. kidney transplant wait-list
Self-harm and suicidal behavior may not always be obvious in people with diabetes
Patient still off injections a year after receiving cells in area near stomach
About 415 million people worldwide have the disease, which is costly to treat but can be prevented
Researchers say new checklist can help determine when low blood sugar should keep you off the road
An individual's level of risk for diabetic eye disease should guide how often they're screened, study says
But doctors making headway with heart complications among these patients
Those with type 2 disease should see eye doc right away, while type 1 patients can wait 5 years
This growing group has double the problems as peers with type 1 disease, study finds